Skip to nav Skip to content

IDSA Media Briefing: Monkeypox Treatment Trials

Facebook Twitter LinkedIn Email

A media briefing hosted by the Infectious Diseases Society of America to discuss tecovirimat (TPOXX) randomized controlled trials.
- Current state of monkeypox outbreak
- Clinical trial enrollment and outreach
- Questions from media

Demetre C. Daskalakis, MD, MPH – White House Monkeypox National Response Team
White House National Monkeypox Response Deputy Coordinator
Director, Division of HIV Prevention, Centers for Disease Control and Prevention

Carl W. Dieffenbach, PhD – National Institute of Allergy and Infectious Diseases
Director, Division of AIDS, National Institute of Allergy and Infectious Diseases

Timothy Wilkin, MD, MPH – Weill Cornell Medicine
Infectious Disease Specialist, Weill Cornell Medicine
Investigator, Cornell Clinical Trials Unit

Amanda Jezek (Moderator)
Senior Vice President, Public Policy and Government Relations—Infectious Diseases Society of America

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.